David R. Wells, Chief Financial Officer at ENDRA Life Sciences Inc. (NDRA), bought 10,000 shares at $1.18 ($12K) on 2019-09-27, disclosed to the SEC on 2019-09-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| SINX | BUY | 2011-01-03 | $1K | — | Filing → |
| SINX | BUY | 2010-12-15 | $1K | — | Filing → |
| SINX | BUY | 2010-12-10 | $1K | — | Filing → |